{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Analysis of DOJ’s FY 2022 FCA Statistics and the Mixed Signals Therein",
"url": "https://www.lexblog.com/2023/02/23/analysis-dojs-fy-2022-fca-statistics-mixed-signals-therein/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-7DREF71N",
"url": "https://www.lexblog.com/lib/7DREF71N/"
},
"datePublished": "2023-02-23T11:39:10-05:00",
"dateModified": "2026-06-17T15:28:54-04:00",
"author": {
"@type": "Person",
"name": "Michael J. Podberesky, David Pivnick, Edwin O. Childs"
},
"sourceOrganization": {
"@type": "Organization",
"name": "McGuireWoods LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Subject to Inquiry",
"about": "Administrative and Regulatory · Health Care and Life Sciences",
"sourceUrl": "https://www.subjecttoinquiry.com/?p=5865",
"sourceStability": "may-move"
}